A 48-year-old man in the UK was bitten by a stray cat, which led to a severe infection caused by a newly discovered bacterium. This case highlights the potential risks of cat bites, especially from stray or feral cats, and the role cats may play in spreading unknown bacteria that could be harmful to humans.
A recent study has found that cannabis-based medicines could be helpful in treating generalized anxiety disorder (GAD), a condition that affects millions of people worldwide. The study, published in Psychopharmacology, suggests that cannabis could improve anxiety symptoms, sleep quality, and overall well-being for people with this condition.
A major global study, co-led by experts from The University of Queensland and Harvard Medical School, has found that one in two people will experience a mental health disorder at some point in their lifetime. This research sheds light on the high prevalence of mental health issues and calls for more support and early intervention.
For the first time ever, patients with severe vision loss caused by age-related macular degeneration (AMD) have regained the ability to read, thanks to a new treatment using stem cells. In a clinical study, two people with wet AMD were able to read again after receiving a special patch made from lab-grown retinal cells.
This breakthrough is part of the London Project to Cure Blindness, a collaboration between University College London and Moorfields Eye Hospital, and is being hailed as a major step forward in treating one of the leading causes of vision loss.
A groundbreaking new technology that blends human brain cells with computer circuits is set to transform the future of robots and AI. The "DishBrain" is a semi-biological chip developed by scientists at Monash University, and it’s already showing impressive potential in the world of artificial intelligence. Now, this exciting research has caught the attention of the military, earning a $407,000 grant to continue its development.
A promising new drug from Eli Lilly is making waves in Alzheimer’s research. The experimental treatment, called donanemab, has shown great potential in slowing down the progression of Alzheimer's disease, especially when used early in patients with mild symptoms.
In a recent study, researchers found that donanemab can slow the decline in memory and thinking skills by 60% if it’s started while patients are still only mildly impaired. The results are based on data from more than 1,700 patients and were presented at the Alzheimer's Association International Conference in Amsterdam.
Imagine falling for someone who never argues, always listens, and texts back instantly. No ghosting, no mixed signals—just 24/7 affection and support. That’s what many people are experiencing with AI girlfriends, and the trend is growing fast.
Charles Brenner's challenge to the longevity industry, which is gaining momentum due to the promise of extending human life expectancy, centers around his skepticism of the claims made by prominent figures and the technologies they promote. A respected biochemist, Brenner has become known as a "longevity skeptic," despite his own groundbreaking work on nicotinamide riboside (NR), a compound linked to NAD+ production, which has shown benefits in aging mice. His concerns focus on the exaggerated promises made by many scientists and companies within the longevity field.
Imagine a tiny wearable device that can track your body’s inflammation levels just by analyzing your sweat. That’s exactly what a team of scientists at Caltech has created—a simple, noninvasive sensor that could make it easier for people with chronic conditions to monitor their health at home.
Imagine if your brain could tell you what song you’ll love before you even know it yourself. Thanks to a new study, we might be closer to that reality than ever.
Researchers in the U.S. have found a way to predict chart-topping songs with almost perfect accuracy — by analyzing brain activity while people listen to music. The results are turning heads in both the science and music worlds, with a whopping 97% accuracy in identifying hit songs. That’s a huge leap from the old methods, which barely scratched 50%.